Thanks Mr Mouse. As we know, most of the questions are scripted to get the message across that Dr Thurn wanted us to take away from the interview. My thoughts are that he was trying to put our mind at ease a bit and that he is looking at non-dilutive ways to fund the Phase 2 MND trial. Also, repeated RA's claims of chatting with BP re the doggie trials, hopefully something will finally come of all these talks as well.
Mr Michael Thurn CEO Interview On Small Caps, page-2
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.5¢ | 17.5¢ | $427.5K | 2.394M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 103443 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 130237 | 3 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
0.005 ( 3.51 %) |
||||
| Open | High | Low | Volume | ||
| 17.5¢ | 18.5¢ | 17.5¢ | 1774886 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| PAA (ASX) Chart |